1) Watched this presentation by Dr. Steve Gardner from PrecisionLife.
Their genetic analysis suggests that ME/CFS is highly polygenic and heterogeneous. They are using their data to make drug repurposing trials more effective, for example on GLP-1 receptor agonists.
